JOHNSON & JOHNSON Quarterly Unrecognized Tax Benefits in USD from Q4 2009 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Johnson & Johnson quarterly Unrecognized Tax Benefits history and growth rate from Q4 2009 to Q3 2024.
  • Johnson & Johnson Unrecognized Tax Benefits for the quarter ending September 29, 2024 was $2.4B, a 4.35% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.4B +$100M +4.35% Sep 29, 2024 10-Q 2024-10-23
Q2 2024 $2.5B +$2B +400% Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $2.5B +$800M +47.1% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $2.49B -$1.23B -33.1% Dec 31, 2023 10-K 2024-02-16
Q3 2023 $2.3B -$1.5B -39.5% Oct 1, 2023 10-Q 2023-10-27
Q2 2023 $500M -$2.9B -85.3% Jul 2, 2023 10-Q 2023-07-31
Q1 2023 $1.7B -$1.6B -48.5% Apr 2, 2023 10-Q 2023-04-28
Q4 2022 $3.72B +$506M +15.8% Jan 1, 2023 10-K 2024-02-16
Q3 2022 $3.8B +$500M +15.2% Oct 2, 2022 10-Q 2022-10-27
Q2 2022 $3.4B +$100M +3.03% Jul 3, 2022 10-Q 2022-07-29
Q1 2022 $3.3B $0 0% Apr 3, 2022 10-Q 2022-04-29
Q4 2021 $3.21B -$50M -1.53% Jan 2, 2022 10-K 2024-02-16
Q3 2021 $3.3B $0 0% Oct 3, 2021 10-Q 2021-10-29
Q2 2021 $3.3B +$200M +6.45% Jul 4, 2021 10-Q 2021-07-29
Q1 2021 $3.3B +$100M +3.13% Apr 4, 2021 10-Q 2021-04-30
Q4 2020 $3.26B -$593M -15.4% Jan 3, 2021 10-K 2024-02-16
Q3 2020 $3.3B -$300M -8.33% Sep 27, 2020 10-Q 2020-10-23
Q2 2020 $3.1B -$200M -6.06% Jun 28, 2020 10-Q 2020-07-24
Q1 2020 $3.2B -$200M -5.88% Mar 29, 2020 10-Q 2020-04-29
Q4 2019 $3.85B +$527M +15.8% Dec 29, 2019 10-K 2023-02-16
Q3 2019 $3.6B +$400M +12.5% Sep 29, 2019 10-Q 2019-10-28
Q2 2019 $3.3B +$100M +3.13% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 $3.4B +$200M +6.25% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $3.33B +$175M +5.55% Dec 30, 2018 10-K 2022-02-17
Q3 2018 $3.2B -$100M -3.03% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $3.2B $0 0% Jul 1, 2018 10-Q 2018-08-02
Q1 2018 $3.2B +$100M +3.23% Apr 1, 2018 10-Q 2018-05-01
Q4 2017 $3.15B +$110M +3.62% Dec 31, 2017 10-K 2021-02-22
Q3 2017 $3.3B +$200M +6.45% Oct 1, 2017 10-Q 2017-11-02
Q2 2017 $3.2B +$100M +3.23% Jul 2, 2017 10-Q 2017-08-03
Q1 2017 $3.1B $0 0% Apr 2, 2017 10-Q 2017-05-08
Q4 2016 $3.04B -$39M -1.27% Jan 1, 2017 10-K 2020-02-18
Q3 2016 $3.1B +$500M +19.2% Oct 2, 2016 10-Q 2016-11-04
Q2 2016 $3.1B +$500M +19.2% Jul 3, 2016 10-Q 2016-08-04
Q1 2016 $3.1B +$600M +24% Apr 3, 2016 10-Q 2016-05-10
Q4 2015 $3.08B +$615M +24.9% Jan 3, 2016 10-K 2019-02-20
Q3 2015 $2.6B +$300M +13% Sep 27, 2015 10-Q 2015-10-30
Q2 2015 $2.6B +$400M +18.2% Jun 28, 2015 10-Q 2015-07-31
Q1 2015 $2.5B +$200M +8.7% Mar 29, 2015 10-Q 2015-05-01
Q4 2014 $2.47B -$264M -9.67% Dec 28, 2014 10-K 2018-02-21
Q3 2014 $2.3B -$100M -4.17% Sep 28, 2014 10-Q 2014-10-30
Q2 2014 $2.2B -$700M -24.1% Jun 29, 2014 10-Q 2014-08-01
Q1 2014 $2.3B -$500M -17.9% Mar 30, 2014 10-Q 2014-05-02
Q4 2013 $2.73B -$325M -10.6% Dec 29, 2013 10-K 2017-02-27
Q3 2013 $2.4B Sep 29, 2013 10-Q 2013-11-04
Q2 2013 $2.9B Jun 30, 2013 10-Q 2013-08-01
Q1 2013 $2.8B Mar 31, 2013 10-Q 2013-05-03
Q4 2012 $3.05B +$355M +13.2% Dec 30, 2012 10-K 2016-02-24
Q4 2011 $2.7B +$392M +17% Jan 1, 2012 10-K 2015-02-24
Q4 2010 $2.31B -$96M -4% Jan 2, 2011 10-K 2014-02-21
Q4 2009 $2.4B Jan 3, 2010 10-K 2013-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.